GlaxoSmithKline
GSK
$43.63
Share price
-2.42%
Change (1 day)
10.29%
Change (1 year)
Categories
Earnings for GlaxoSmithKline (GSK)
Earnings in 2022 (TTM): $9.80 B
According to GlaxoSmithKline's latest financial reports the company's current earnings (TTM) are $9.80 B. In 2021 the company made an earning of $8.48 B a decrease over its 2020 earnings that were of $9.88 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for GlaxoSmithKline from 2001 to 2022
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $9.80 B | 15.67% |
| 2021 | $8.48 B | -14.23% |
| 2020 | $9.88 B | 9.11% |
| 2019 | $9.06 B | 23.27% |
| 2018 | $7.35 B | 32.34% |
| 2017 | $5.55 B | 58.51% |
| 2016 | $3.50 B | -79.07% |
| 2015 | $16.74 B | 176.71% |
| 2014 | $6.05 B | -48.42% |
| 2013 | $11.73 B | -1.6% |
| 2012 | $11.92 B | -11.36% |
| 2011 | $13.45 B | 118.02% |
| 2010 | $6.16 B | -55.03% |
| 2009 | $13.71 B | 0.19% |
| 2008 | $13.69 B | 9.8% |
| 2007 | $12.47 B | -12.68% |
| 2006 | $14.28 B | 1437.47% |
| 2005 | $0.92 B | -91.8% |
| 2004 | $11.32 B | 2.55% |
| 2003 | $11.04 B | 12.52% |
| 2002 | $9.81 B | -6.41% |
| 2001 | $10.48 B |